Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
Clinical trial NCT07235059 · RECRUITING
Trial details
- NCT number
- NCT07235059
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-20
- Primary completion
- 2028-01-21
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.